Search research articles
Contact Us
Filters
Showing results (51-60 of 86) with videos related to
Page
of 9
Sort By:
Vaccine
|
June 19, 2016
Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children
Abigail Hankin-Wei, David B Rein, Alfonso Hernandez-Romieu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Public Health
Melinda C Power, Kan Z Gianattasio, Wachsmuth Jason, et al.
Investigative Ophthalmology & Visual Science
|
January 15, 2010
The cost of visual impairment: purposes, perspectives, and guidance
Kevin D Frick, Steven M Kymes, Paul P Lee, et al.
Ophthalmology
|
March 17, 2009
The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States
David B Rein, John S Wittenborn, Paul P Lee, et al.
JAMA Ophthalmology
|
May 13, 2021
Prevalence of Visual Acuity Loss or Blindness in the US: A Bayesian Meta-analysis
Abraham D Flaxman, John S Wittenborn, Toshana Robalik, et al.
JAMA Ophthalmology
|
November 3, 2022
Prevalence of Age-Related Macular Degeneration in the US in 2019
David B Rein, John S Wittenborn, Zeb Burke-Conte, et al.
Preventive Medicine Reports
|
June 30, 2023
Effectiveness evaluation of a hypertension management program in a Federally Qualified Health Center (FQHC)
Kincaid Lowe Beasley, Aisha Tucker-Brown, David B Rein, et al.
Ophthalmology
|
July 15, 2020
Vision Impairment and Blindness Prevalence in the United States: Variability of Vision Health Responses across Multiple National Surveys
David B Rein, Phoebe A Lamuda, John S Wittenborn, et al.
Journal of the American Geriatrics Society
|
December 9, 2024
Association between visual impairment and recurrent hospitalizations in older US adults
Niranjani Nagarajan, Karolina Leziak, Yunshu Zhou, et al.
JAMA Ophthalmology
|
March 3, 2022
Trends in Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Medicare Part B Fee-for-Service Beneficiaries
Elizabeth A Lundeen, Linda J Andes, David B Rein, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 86) with videos related to
Sort By:
Page
of 9
Vaccine
|
June 19, 2016
Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children
Abigail Hankin-Wei, David B Rein, Alfonso Hernandez-Romieu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Public Health
Melinda C Power, Kan Z Gianattasio, Wachsmuth Jason, et al.
Investigative Ophthalmology & Visual Science
|
January 15, 2010
The cost of visual impairment: purposes, perspectives, and guidance
Kevin D Frick, Steven M Kymes, Paul P Lee, et al.
Ophthalmology
|
March 17, 2009
The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States
David B Rein, John S Wittenborn, Paul P Lee, et al.
JAMA Ophthalmology
|
May 13, 2021
Prevalence of Visual Acuity Loss or Blindness in the US: A Bayesian Meta-analysis
Abraham D Flaxman, John S Wittenborn, Toshana Robalik, et al.
JAMA Ophthalmology
|
November 3, 2022
Prevalence of Age-Related Macular Degeneration in the US in 2019
David B Rein, John S Wittenborn, Zeb Burke-Conte, et al.
Preventive Medicine Reports
|
June 30, 2023
Effectiveness evaluation of a hypertension management program in a Federally Qualified Health Center (FQHC)
Kincaid Lowe Beasley, Aisha Tucker-Brown, David B Rein, et al.
Ophthalmology
|
July 15, 2020
Vision Impairment and Blindness Prevalence in the United States: Variability of Vision Health Responses across Multiple National Surveys
David B Rein, Phoebe A Lamuda, John S Wittenborn, et al.
Journal of the American Geriatrics Society
|
December 9, 2024
Association between visual impairment and recurrent hospitalizations in older US adults
Niranjani Nagarajan, Karolina Leziak, Yunshu Zhou, et al.
JAMA Ophthalmology
|
March 3, 2022
Trends in Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Medicare Part B Fee-for-Service Beneficiaries
Elizabeth A Lundeen, Linda J Andes, David B Rein, et al.
Page
of 9